IMMUNISATION WITH A POLYVALENT PNEUMOCOCCAL VACCINE. Reduction of Adult Respiratory Mortality in a New Guinea Highlands Community

I. D. Riley, M. Andrews, R. Howard, P. I. Tarr, M. Pfeiffer, P. Challands, G. Jennison, R. M. Douglas

Research output: Contribution to journalArticlepeer-review

141 Scopus citations

Abstract

A double-blind controlled trial of a 14-valent pneumococcal polysaccharide vaccine was carried out in 11 958 adults at Tari in the Papua New Guinea Highlands. Pneumococcal infection, confirmed by blood-culture and lung aspirate, was less in the vaccinated group by 84%. Mortality from pneumonia was less by 44%.

Original languageEnglish
Pages (from-to)1338-1341
Number of pages4
JournalThe Lancet
Volume309
Issue number8026
DOIs
StatePublished - Jun 25 1977

Fingerprint

Dive into the research topics of 'IMMUNISATION WITH A POLYVALENT PNEUMOCOCCAL VACCINE. Reduction of Adult Respiratory Mortality in a New Guinea Highlands Community'. Together they form a unique fingerprint.

Cite this